Related Experiment Videos
Differential gene expression identified in complete hydatidiform mole by combining suppression subtractive
H-C Feng1, S-W Tsao, H Y S Ngan
1Department of Anatomy, The University of Hong Kong, Pokfulam, Queen Mary Hospital, Hong Kong, China.
Placenta
|July 20, 2005
Summary
Complete hydatidiform mole (CHM), a pregnancy condition with paternal DNA, shows altered gene expression. Key genes like CGB and KIAA1200 were upregulated, while SPP1 was downregulated, offering insights into CHM development.
Area of Science:
- Reproductive Biology
- Genetics
- Molecular Pathology
Background:
- Complete hydatidiform mole (CHM) is a gestational trophoblastic disease originating solely from paternal chromosomes.
- CHM possesses unpredictable malignant potential, necessitating research into its molecular pathogenesis.
Purpose of the Study:
- To investigate and compare gene expression patterns between CHM and normal first-trimester placenta.
- To identify differentially expressed genes contributing to CHM development and progression.
Main Methods:
- Suppression subtractive hybridization (SSH) combined with cDNA microarray analysis was employed.
- Gene expression profiles were compared between 14 genotyped CHM samples and 15 normal placentas.
- Quantitative real-time polymerase chain reaction (PCR) validated key gene expression changes.
Main Results:
- Thirteen differentially expressed gene transcripts were identified using cDNA microarray.
- Significant upregulation of human chorionic gonadotropin beta subunit (CGB) and KIAA1200 was observed in CHM.
- Osteopontin (SPP1) showed significant downregulation in CHM compared to normal placental tissue.
Conclusions:
- The identified candidate genes, including CGB, KIAA1200, and SPP1, play a role in the molecular mechanisms underlying CHM.
- Understanding these gene expression alterations provides crucial insights into CHM development and malignant transformation.
- Further research into these genes may lead to improved diagnostic or therapeutic strategies for CHM.